Contribution of glutathione and MRP-mediated efflux to intracellular oxaliplatin accumulation

International Journal of Clinical Pharmacology and Therapeutics

Volumn 48, Issue 7, 2010, Pages 445-447

  Mohn, C ^a   Kalayda, G V ^a   Hacker H G ^a   Gutschow M ^a   Metzger, S ^b   Jaehde, U ^a  

^a UNIVERSITY OF BONN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Efflux; Glutathione; MRP1; MRP2; Oxaliplatin; Resistance

Indexed keywords

FORMIC ACID; GLUTATHIONE; METHANOL; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; OXALIPLATIN;

AQUEOUS SOLUTION; ATOMIC ABSORPTION SPECTROMETRY; CANCER CELL CULTURE; COLON ADENOCARCINOMA; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ACCUMULATION; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; HUMAN CELL; INCUBATION TIME; PROTEIN TRANSPORT; RECTUM CARCINOMA;

EID: 77954936807     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP48445     Document Type: Conference Paper

References (4)

1. Hall MD, Okabe M, Shen DW, Liang XJ, Gottesman MM. The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy. Annu Rev Pharmacol Toxicol. 2008; 48: 495-535. (Pubitemid 351738162)
2. Ishikawa T, Ali-Osman F. Glutathione-associated cis- diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance. J Biol Chem. 1993; 268: 20116-20125. (Pubitemid 23278910)
3. Wortelboer HM, Balvers MGJ, Usta M, van Bladeren PJ, Cnubben NHP. Glutathione-dependent interaction of heavy metal compounds with multidrug resistance proteins MRP1 and MRP2. Environ Toxicol Pharmacol. 2008; 26: 102-108.
4. Leyers S, Häcker HG, Wiendlocha J, Gütschow M, Wiese M. A 4-aminobenzoic acid derivative as novel lead for selective inhibitors of multidrug resistance-associated proteins. Bioorg Med Chem Lett. 2008; 18: 4761-4763.